4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-038568
Director sold 2,500 shares at an average $44.78 ($111,944)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Carol Giltner Director | 2018-06-18 | Sale | −2,100 | $44.68 | $93,828 | 110,592 | D |
| Gallagher Carol Giltner Director | 2018-06-18 | Sale | −400 | $45.29 | $18,116 | 110,192 | D |
| Open-market sales · 2,500 sh · avg $44.78 · $111,944 | |||||||
Loading xslF345X03/doc4.xml…